{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:39:11Z","timestamp":1787063951244,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02779-1","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:08:45Z","timestamp":1749139725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating the impact of berberine on autophagy-mediated drug resistance in chronic lymphocytic leukemia tumor cells"],"prefix":"10.1007","volume":"42","author":[{"given":"Ghazaleh","family":"Alizad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Hemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahador","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Kokhaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Memarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"publisher","first-page":"ii113","DOI":"10.1093\/annonc\/mdi731","volume":"16","author":"P Kokhaei","year":"2005","unstructured":"Kokhaei P, Palma M, Mellstedt H, Choudhury A. Biology and treatment of chronic lymphocytic leukemia. Ann Oncol. 2005;16:ii113\u201323.","journal-title":"Ann Oncol"},{"issue":"2","key":"2779_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/cells8020103","volume":"8","author":"M Djavaheri-Mergny","year":"2019","unstructured":"Djavaheri-Mergny M, Giuriato S, Tschan MP, Humbert M. Therapeutic modulation of autophagy in leukaemia and lymphoma. Cells. 2019;8(2):103.","journal-title":"Cells"},{"issue":"11","key":"2779_CR3","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/ajh.25595","volume":"94","author":"M Hallek","year":"2019","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019;94(11):1266\u201387.","journal-title":"Am J Hematol"},{"issue":"17","key":"2779_CR4","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.7314\/APJCP.2015.16.17.7759","volume":"16","author":"F Koohi","year":"2015","unstructured":"Koohi F, Shamlou R, Eslami S, Ghojogh ZM, Kor Y, Rafiemanesh H. Leukemia in Iran: epidemiology and morphology trends. Asian Pac J Cancer Prev. 2015;16(17):7759\u201363.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"25","key":"2779_CR5","first-page":"2745","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL, Blood. J Am Soc Hematol. 2018;131(25):2745\u201360.","journal-title":"J Am Soc Hematol"},{"issue":"11","key":"2779_CR6","first-page":"715","volume":"76","author":"M Mohammadlou","year":"2019","unstructured":"Mohammadlou M, Abdollahi M, Kokhaei P. Chronic lymphocytic leukemia, biology, new diagnosis and treatment. Tehran Univ Med Sci J. 2019;76(11):715\u201323.","journal-title":"Tehran Univ Med Sci J"},{"issue":"1","key":"2779_CR7","first-page":"1","volume":"3","author":"TJ Kipps","year":"2017","unstructured":"Kipps TJ, Stevenson FK, Wu CJ, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3(1):1\u201322.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2779_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/leu.2014.19","volume":"28","author":"V El-Khoury","year":"2014","unstructured":"El-Khoury V, Pierson S, Szwarcbart E, et al. Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia. Leukemia. 2014;28(8):1636\u201346.","journal-title":"Leukemia"},{"key":"2779_CR9","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409001306","volume":"11","author":"MT Rosenfeldt","year":"2009","unstructured":"Rosenfeldt MT, Ryan KM. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med. 2009;11: e36.","journal-title":"Expert Rev Mol Med"},{"key":"2779_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fphar.2020.00408","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front Pharmacol. 2020;11:408.","journal-title":"Front Pharmacol"},{"key":"2779_CR11","unstructured":"Broad targeting of resistance to apoptosis in cancer. Seminars in cancer biology. 2015. Elsevier."},{"issue":"1","key":"2779_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00920-3","volume":"13","author":"S Yuan","year":"2020","unstructured":"Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol. 2020;13(1):1\u201319.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2779_CR13","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.7150\/ijbs.73504","volume":"18","author":"H Dong","year":"2022","unstructured":"Dong H, Zhang L, Liu S. Targeting HMGB1: an available therapeutic strategy for breast cancer therapy. Int J Biol Sci. 2022;18(8):3421.","journal-title":"Int J Biol Sci"},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02387-9","volume":"21","author":"W Lai","year":"2021","unstructured":"Lai W, Li X, Kong Q, et al. Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells. Cancer Cell Int. 2021;21:1\u201321.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2779_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4161\/auto.8.2.18940","volume":"8","author":"J Huang","year":"2012","unstructured":"Huang J, Liu K, Yu Y, et al. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy. 2012;8(2):275\u20137.","journal-title":"Autophagy"},{"issue":"2","key":"2779_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/10428194.2011.616962","volume":"53","author":"L Yang","year":"2012","unstructured":"Yang L, Yu Y, Kang R, et al. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma. 2012;53(2):315\u201322.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2779_CR17","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1002\/jcp.28325","volume":"234","author":"R Mohammadinejad","year":"2019","unstructured":"Mohammadinejad R, Ahmadi Z, Tavakol S, Ashrafizadeh M. Berberine as a potential autophagy modulator. J Cell Physiol. 2019;234(9):14914\u201326.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2779_CR18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/ptr.6945","volume":"35","author":"M Mohammadlou","year":"2021","unstructured":"Mohammadlou M, Abdollahi M, Hemati M, et al. Apoptotic effect of berberine via Bcl-2, ROR1, and mir-21 in patients with B-chronic lymphocytic leukemia. Phytother Res. 2021;35(4):2025\u201333.","journal-title":"Phytother Res"},{"issue":"15","key":"2779_CR19","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/nar\/gky423","volume":"46","author":"W Li","year":"2018","unstructured":"Li W, Li Q, Kang S, et al. CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data. Nucleic Acids Res. 2018;46(15):e89\u2013e89.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2779_CR20","doi-asserted-by":"publisher","first-page":"12349","DOI":"10.3390\/molecules190812349","volume":"19","author":"LM Guam\u00e1n Ortiz","year":"2014","unstructured":"Guam\u00e1n Ortiz LM, Lombardi P, Tillhon M, Scovassi AI. Berberine, an epiphany against cancer. Molecules. 2014;19(8):12349\u201367.","journal-title":"Molecules"},{"issue":"15","key":"2779_CR21","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.2174\/1871520622666220324092302","volume":"22","author":"MR Mazandaranian","year":"2022","unstructured":"Mazandaranian MR, Dana PM, Asemi Z, Hallajzadeh J, Mansournia MA, Yousefi B. Effects of berberine on leukemia with a focus on its molecular targets. Anti-Cancer Agents Med Chem. 2022;22(15):2766\u201374.","journal-title":"Anti-Cancer Agents Med Chem"},{"issue":"33","key":"2779_CR22","doi-asserted-by":"publisher","first-page":"53515","DOI":"10.18632\/oncotarget.10650","volume":"7","author":"X Liu","year":"2016","unstructured":"Liu X, Wang A, Liang X, et al. Simultaneous inhibition of Vps34 kinase would enhance PI3K\u03b4 inhibitor cytotoxicity in the B-cell malignancies. Oncotarget. 2016;7(33):53515.","journal-title":"Oncotarget"},{"issue":"1","key":"2779_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24125","volume":"36","author":"H Samiei","year":"2022","unstructured":"Samiei H, Ajam F, Gharavi A, et al. Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC). J Clin Lab Anal. 2022;36(1): e24125.","journal-title":"J Clin Lab Anal"},{"key":"2779_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00262-008-0589-z","volume":"58","author":"T Kazemi","year":"2009","unstructured":"Kazemi T, Asgarian-Omran H, Memarian A, et al. Low representation of Fc receptor-like 1\u20135 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother. 2009;58:989\u201396.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2779_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ijms22010179","volume":"22","author":"CW Yun","year":"2020","unstructured":"Yun CW, Jeon J, Go G, Lee JH, Lee SH. The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy. Int J Mol Sci. 2020;22(1):179.","journal-title":"Int J Mol Sci"},{"key":"2779_CR26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2147\/DDDT.S239247","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Liu P, Xu T, et al. Berberine induces autophagic cell death in acute lymphoblastic leukemia by inactivating AKT\/mTORC1 signaling. Drug Design, Develop Therap. 2020;14:1813\u201323.","journal-title":"Drug Design, Develop Therap"},{"key":"2779_CR27","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fphar.2019.01461","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Sheng J, Li G, et al. Effects of berberine and its derivatives on cancer: a systems pharmacology review. Front Pharmacol. 2020;10:1461.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2779_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1124\/mol.114.091850","volume":"85","author":"A Thorburn","year":"2014","unstructured":"Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014;85(6):830\u20138.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"2779_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.leukres.2015.02.008","volume":"39","author":"L Kristensen","year":"2015","unstructured":"Kristensen L, Kristensen T, Abildgaard N, et al. High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia. Leuk Res. 2015;39(6):555\u201360.","journal-title":"Leuk Res"},{"issue":"4","key":"2779_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cncr.29794","volume":"122","author":"PA Thompson","year":"2016","unstructured":"Thompson PA, O\u2019Brien SM, Xiao L, et al. \u03b22-microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia. Cancer. 2016;122(4):565\u201373.","journal-title":"Cancer"},{"key":"2779_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.leukres.2017.12.007","volume":"66","author":"Y-L Kong","year":"2018","unstructured":"Kong Y-L, Huang Y, Wu J-Z, et al. Expression of autophagy related genes in chronic lymphocytic leukemia is associated with disease course. Leuk Res. 2018;66:8\u201314.","journal-title":"Leuk Res"},{"issue":"3","key":"2779_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/ajco.13449","volume":"17","author":"RM Usman","year":"2021","unstructured":"Usman RM, Razzaq F, Akbar A, et al. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance. Asia Pac J Clin Oncol. 2021;17(3):193\u2013208.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2779_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152048","volume":"226","author":"J Schmohl","year":"2021","unstructured":"Schmohl J, Guenther T, Sutanto W, et al. Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse. Immunobiology. 2021;226(1): 152048.","journal-title":"Immunobiology"},{"issue":"3","key":"2779_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1189\/jlb.0709502","volume":"87","author":"NC Dempsey","year":"2010","unstructured":"Dempsey NC, Leoni F, Ireland HE, Hoyle C, Williams JH. Differential heat shock protein localization in chronic lymphocytic leukemia. J Leukoc Biol. 2010;87(3):467\u201376.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"2779_CR35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/cancers15030984","volume":"15","author":"V Cabaud-Gibouin","year":"2023","unstructured":"Cabaud-Gibouin V, Durand M, Qu\u00e9r\u00e9 R, Girodon F, Garrido C, Jego G. Heat-shock proteins in leukemia and lymphoma: multitargets for innovative therapeutic approaches. Cancers. 2023;15(3):984.","journal-title":"Cancers"},{"issue":"6","key":"2779_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cmet.2011.04.008","volume":"13","author":"D Tang","year":"2011","unstructured":"Tang D, Kang R, Livesey KM, et al. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab. 2011;13(6):701\u201311.","journal-title":"Cell Metab"},{"issue":"1","key":"2779_CR37","first-page":"4961407","volume":"2022","author":"L Ma","year":"2022","unstructured":"Ma L, Fang X, Yin X, Li Y. Investigation of molecular mechanism of Banxia xiexin decoction in colon cancer via network pharmacology and in vivo studies. Evid-Based Complement Alter Med. 2022;2022(1):4961407.","journal-title":"Evid-Based Complement Alter Med"},{"key":"2779_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuro.2022.01.011","volume":"89","author":"A Yardim","year":"2022","unstructured":"Yardim A, Gur C, Comakli S, et al. Investigation of the effects of berberine on bortezomib-induced sciatic nerve and spinal cord damage in rats through pathways involved in oxidative stress and neuro-inflammation. Neurotoxicology. 2022;89:127\u201339.","journal-title":"Neurotoxicology"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02779-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:40:12Z","timestamp":1751517612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02779-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02779-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Golestan\u00a0University of Medical Sciences\u00a0(IR.GOUMS.REC.1400.436).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"240"}}